CytomX Therapeutics Return on Investment 2014-2022 | CTMX

Current and historical return on investment (ROI) values for CytomX Therapeutics (CTMX) over the last 10 years.
CytomX Therapeutics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-09-30 $-0.10B inf%
2022-06-30 $-0.10B inf%
2022-03-31 $-0.09B inf%
2021-12-31 $-0.08B inf%
2021-09-30 $-0.07B inf%
2021-06-30 $-0.07B inf%
2021-03-31 $-0.06B inf%
2020-12-31 $-0.05B inf%
2020-09-30 $-0.07B inf%
2020-06-30 $-0.08B inf%
2020-03-31 $-0.10B inf%
2019-12-31 $-0.11B inf%
2019-09-30 $-0.10B inf%
2019-06-30 $-0.10B inf%
2019-03-31 $-0.08B inf%
2018-12-31 $-0.08B inf%
2018-09-30 $-0.05B inf%
2018-06-30 $-0.04B inf%
2018-03-31 $-0.05B inf%
2017-12-31 $-0.05B inf%
2017-09-30 $-0.06B inf%
2017-06-30 $-0.06B inf%
2017-03-31 $-0.05B inf%
2016-12-31 $-0.06B inf%
2016-09-30 $-0.06B inf%
2016-06-30 $-0.05B inf%
2016-03-31 $-0.05B inf%
2015-12-31 $-0.03B inf%
2015-06-30 $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.115B $0.070B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.122B 8.73
GSK (GSK) United Kingdom $75.233B 9.43
Bio-Rad Laboratories (BIO.B) United States $13.735B 32.61
QIAGEN (QGEN) Netherlands $10.461B 19.38
Ginkgo Bioworks Holdings (DNA) United States $2.529B 0.00
Arcus Biosciences (RCUS) United States $1.165B 0.00
Biohaven (BHVN) United States $0.882B 0.00
Emergent Biosolutions (EBS) United States $0.391B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.153B 0.00
Enzo Biochem (ENZ) United States $0.102B 0.00
SQZ Biotechnologies (SQZ) United States $0.018B 0.00
Gelesis Holdings (GLS) United States $0.011B 0.00